David Bench's most recent trade in Enzo Biochem, Inc. was a trade of 3,500 Common Stock, $0.01 Par Value done at an average price of $2.2 . Disclosure was reported to the exchange on June 14, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Enzo Biochem, Inc. | David Bench | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.15 per share. | 14 Jun 2022 | 3,500 | 6,000 (0%) | 0% | 2.2 | 7,525 | Common Stock, $0.01 Par Value |
| Enzo Biochem, Inc. | David Bench | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 2.90 per share. | 13 Apr 2022 | 1,620 | 2,500 (0%) | 0% | 2.9 | 4,698 | Common Stock, $0.01 Par Value |
| Enzo Biochem, Inc. | David Bench | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 2.90 per share. | 13 Apr 2022 | 880 | 880 (0%) | 0% | 2.9 | 2,552 | Common Stock, $0.01 Par Value |
| Enzo Biochem, Inc. | David Bench | CFO, SVP, Treasurer and CS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2022 | 87,500 | 87,500 | - | - | Stock Option (to acquire Common Stock) | |
| Enzo Biochem, Inc. | David Bench | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 87,500 | 87,500 | - | - | Stock Option (to acquire Common Stock) | |
| Enzo Biochem, Inc. | David Bench | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jan 2021 | 55,400 | 110,800 | - | - | Stock Option (to acquire Common Stock) |